BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Fast Melt Tablets Market Size Reach USD 11.41 Billion by 2032, Growing at a CAGR of 9.1% from 2024 to 2032

  June 10, 2025

   · 

  1 min read
• Press Releases

  Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention

  June 10, 2025

   · 

  8 min read
• Press Releases

  AIML Strengthens IP Portfolio with Provisional Patents for AI Driven ECG Signal Processing

  June 10, 2025

   · 

  4 min read
• Press Releases

  Neurenati Announces its First Scientific and Clinical Advisory Board Meeting with KOLs to Advance the Development of NEU-001, a Promising Cure for Hirschsprung Disease

  June 10, 2025

   · 

  2 min read
• Press Releases

  Paige and Breast International Group (BIG) Announce Strategic Partnership to Advance AI-Driven Breast Cancer Research and Patient Care

  June 10, 2025

   · 

  5 min read
• Press Releases

  Travere Therapeutics Launches “Play It Forward” Campaign to Celebrate the FSGS Community on Inaugural Awareness Day

  June 10, 2025

   · 

  3 min read
• Press Releases

  Global Cognitive Behavioral Therapy Market Set to Witness Booming Growth, Reaching USD 21.62 Bn by 2031 | CBT Solutions, Mental Health Innovators

  June 10, 2025

   · 

  1 min read
• Press Releases

  Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the Summit and MaculArt

  June 10, 2025

   · 

  2 min read
• Press Releases

  Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

  June 10, 2025

   · 

  6 min read
• Press Releases

  ImmVira Announces First Patient Dosed in a Multi-Regional Phase II Clinical Trial Evaluating MVR-T3011 Oncolytic Immunotherapy in Patients with BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

  June 10, 2025

   · 

  3 min read